logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
S

Scott J. Johnson

analysis group inc.

25H指数
114论文数
2.0K被引数
收录论文 39
发表时间
logo
Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis
errDERMATOLOGY AND THERAPY
IF4.2
err2023-09-01
err20
errOAAI
errSilverberg, Jonathan, I; Hong, H. Chih-ho; Calimlim, Brian M.; Lee, Wan-Ju; Teixeira, Henrique D.; Collins, Eric B.; Crowell, Marjorie M.; Johnson, Scott J.; Armstrong, April W.
err分享
err收藏
Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2023-06-20
err0
PREAI
errSilverberg, Jonathan, I; Hong, H. Chih-ho; Thyssen, Jacob P.; Calimlim, Brian M.; Lee, Wan-Ju; Teixeira, Henrique D.; Collins, Eric B.; Crowell, Marjorie M.; Johnson, Scott J.; Armstrong, April W.
err分享
err收藏
Indirect treatment comparison of oral versus injectable azacitidine as maintenance therapy for acute myeloid leukemia
errFUTURE ONCOLOGY
IF2.6
err2022-12-12
err2
errOAAI
errTabah, Ashley; Huggar, David; Wang, Si-Tien; Johnson, Scott J.; Copher, Ronda M.; O'Connell, Thomas; McBride, Ali; LeBlanc, Thomas W.
err分享
err收藏
Cost-Effectiveness of Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma: No Impact of Site of Care复发或难治性大b细胞淋巴瘤患者嵌合抗原受体T细胞治疗的成本效益: 护理部位无影响
errADVANCES IN THERAPY
IF4
err2022-06-11
err12
errOAAI
errJoyner, Alice Kate Cummings; Snider, Julia Thornton; Wade, Sally West; Wang, Si-Tien; Buessing, Marric G.; Johnson, Scott; Gergis, Usama
err分享
err收藏
Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis
errDERMATOLOGY AND THERAPY
IF4.2
err2022-04-18
err37
errOAAI
errSilverberg, Jonathan I.; Hong, H. Chih-ho; Thyssen, Jacob P.; Calimlim, Brian M.; Joshi, Avani; Teixeira, Henrique D.; Collins, Eric B.; Crowell, Marjorie M.; Johnson, Scott J.; Armstrong, April W.
err分享
err收藏
Letter: is unrealised adult height resulting from paediatric Crohn's disease associated with a potential reduction in lifetime earnings?
errALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
err2020-07-13
err1
errOAAI
errHron, Bridget M.; Cohen, Russell D.; Johnson, Scott J.; Skup, Martha; Chao, Jingdong; Kahn, Stacy A.
err分享
err收藏
Important Considerations in Modeling the Cost-Effectiveness for the First Food and Drug Administration-Approved Gene Therapy and Implications for Future One-Time Therapies
errVALUE IN HEALTH
IF6
err2019-08-01
err6
errOAAI
errBuessing, Marric; O'Connell, Thomas; Johnson, Scott; Pitluck, Sarah; Ciulla, Thomas A.
err分享
err收藏
Estimation of impact of RPE65-mediated inherited retinal disease on quality of life and the potential benefits of gene therapy
errBRITISH JOURNAL OF OPHTHALMOLOGY
IF3.5
err2019-01-18
err45
errOAAI
errLloyd, Andrew; Piglowska, Natalia; Ciulla, Thomas; Pitluck, Sarah; Johnson, Scott; Buessing, Marric; O'Connell, Thomas
err分享
err收藏
Risk of Developing Comorbidities Among Women with Endometriosis: A Retrospective Matched Cohort Study
errJOURNAL OF WOMENS HEALTH
IF1.9
err2018-09-01
err68
PREAI
errSurrey, Eric S.; Soliman, Ahmed M.; Johnson, Scott J.; Davis, Matthew; Castelli-Haley, Jane; Snabes, Michael C.
err分享
err收藏
Early versus delayed hepatitis C treatment provides increased health benefits at lower costs: A pan-genotypic cost effectiveness analysis set in Scotland
errJOURNAL OF HEPATOLOGY
IF33
err2018-04-01
err1
PREAI
errPinsky, B.; Mitchell, D.; Sanchez, Y.; Johnson, S.; Sammy, S.
err分享
err收藏
Changes in Healthcare Spending After Diagnosis of Comorbidities Among Endometriosis Patients: A Difference-in-Differences Analysis
errADVANCES IN THERAPY
IF4
err2017-11-03
err6
errOAAI
errEpstein, Andrew J.; Soliman, Ahmed M.; Davis, Matthew; Johnson, Scott J.; Snabes, Michael C.; Surrey, Eric S.
err分享
err收藏
Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States
errADVANCES IN THERAPY
IF4
err2016-06-24
err9
PREAI
errSaab, Sammy; Virabhak, Suchin; Parise, Helene; Johnson, Scott; Wang, Alice; Misurski, Derek; Gonzalez, Yuri Sanchez; Juday, Timothy
err分享
err收藏
REDUCTIONS IN LIFETIME RISKS OF LIVER-RELATED MORBIDITY AND MORTALITY ASSOCIATED WITH NOVEL DIRECT-ACTING ANTIVIRAL REGIMENS RECOMMENDED FOR TREATING GENOTYPE 4 NON-CIRRHOTIC HEPATITIS C PATIENTS IN THE UNITED STATES
errJOURNAL OF HEPATOLOGY
IF33
err2016-01-01
err0
PREAI
errSaab, S.; Parise, H.; Virabhak, S.; Wang, A.; Marx, S.; Johnson, S.
err分享
err收藏
COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR FOR PATIENTS WITH CHRONIC HCV IN THE NETHERLANDS
errVALUE IN HEALTH
IF6
err2015-11-01
err1
errOAAI
errGaultney, J.; de Knegt, R. J.; Fassler, P.; Visser, S.; Johnson, S.
err分享
err收藏
ANALYSIS OF OUTCOMES AFTER NON-MEDICAL SWITCHING OF ANTI-TUMOR NECROSIS FACTOR AGENTS
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2015-06-01
err1
PREAI
errGibofsky, A.; Skup, M.; Johnson, S.; Chao, J.; Rubin, D.
err分享
err收藏
LONG-TERM COST PER SUSTAINED VIROLOGIC RESPONSE IN PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C VIRUS TREATED WITH VIEKIRA PAK plus /- RIBAVIRIN AND STANDARD OF CARE IN THE US
errVALUE IN HEALTH
IF6
err2015-05-01
err1
errOAAI
errVirabhak, S.; Johnson, S.; Parise, H.; Saab, S.; Juday, T.; Marx, S.; Sanchez, Y.; Wang, A.
err分享
err收藏
COST-EFFECTIVENESS OF TREATING DIFFERENT STAGES OF GENOTYPE 1 HEPATITIS C VIRUS (HCV) WITH ABBVIE 3D (ABT-450/RITONAVIR/OMBITASVIR AND DASABUVIR) plus /- RIBAVIRIN COMPARED TO NO TREATMENT IN THE UNITED STATES
errJOURNAL OF HEPATOLOGY
IF33
err2015-04-01
err1
PREAI
errJohnson, S. J.; Misurski, D. A.; Juday, T. R.; Samp, J. C.; Marx, S. E.; Parise, H.; Virabhak, S.; Saab, S.
err分享
err收藏
PERCENT OF SUBJECTS EXPERIENCING LIVER MORBIDITY OVER A LIFETIME HORIZON WITH ABBVIE 3D (ABT-450/RITONAVIR/OMBITASVIR AND DASABUVIR) VERSUS NO TREATMENT
errJOURNAL OF HEPATOLOGY
IF33
err2015-04-01
err0
PREAI
errJohnson, S. J.; Parise, H.; Virabhak, S.; Misurski, D. A.; Juday, T. R.; Samp, J. C.; Marx, S. E.; Saab, S.
err分享
err收藏
REDUCTION IN ANNUAL MEDICAL COSTS WITH EARLY TREATMENT OF HCV USING ABBVIE 3D (ABT-450/RITONAVIR/OMBITASVIR AND DASABUVIR) plus /- RIBAVIRIN IN THE UNITED STATES
errJOURNAL OF HEPATOLOGY
IF33
err2015-04-01
err2
PREAI
errMisurski, D. A.; Johnson, S. J.; Samp, J. C.; Marx, S. E.; Juday, T. R.; Virabhak, S.; Parise, H.; Saab, S.
err分享
err收藏
Importance of Transparency in Assessing the Feasibility of Modeling Rare Disease
errMEDICAL DECISION MAKING
IF2.3
err2014-12-12
err1
errOAAI
errJohnson, Scott J.; Davis, Matthew R.; Wang, Si-Tien
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
E
Edward V. Loftus
H 指数: 127 · 论文数: 1.3K
J
Jonathan I. Silverberg
H 指数: 99 · 论文数: 1.2K
J
Jacob P. Thyssen
H 指数: 90 · 论文数: 986
A
Andrew Siderowf
H 指数: 83 · 论文数: 362
A
April W. Armstrong
H 指数: 71 · 论文数: 858
查看更多